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Background: The virus-host arms race is a major theater for evolutionary innovation. Archaea and bacteria have
evolved diverse, elaborate antivirus defense systems that function on two general principles: i) immune systems
that discriminate self DNA from nonself DNA and specifically destroy the foreign, in particular viral, genomes,
whereas the host genome is protected, or ii) programmed cell suicide or dormancy induced by infection.
Presentation of the hypothesis: Almost all genomic loci encoding immunity systems such as CRISPR-Cas,
restriction-modification and DNA phosphorothioation also encompass suicide genes, in particular those encoding
known and predicted toxin nucleases, which do not appear to be directly involved in immunity. In contrast, the
immunity systems do not appear to encode antitoxins found in typical toxin-antitoxin systems. This raises the
possibility that components of the immunity system themselves act as reversible inhibitors of the associated toxin
proteins or domains as has been demonstrated for the Escherichia coli anticodon nuclease PrrC that interacts with
the PrrI restriction-modification system. We hypothesize that coupling of diverse immunity and suicide/dormancy
systems in prokaryotes evolved under selective pressure to provide robustness to the antivirus response. We further
propose that the involvement of suicide/dormancy systems in the coupled antivirus response could take two
distinct forms:
1) induction of a dormancy-like state in the infected cell to ‘buy time’ for activation of adaptive immunity;
2) suicide or dormancy as the final recourse to prevent viral spread triggered by the failure of immunity.
Testing the hypothesis: This hypothesis entails many experimentally testable predictions. Specifically, we predict
that Cas2 protein present in all cas operons is a mRNA-cleaving nuclease (interferase) that might be activated at an
early stage of virus infection to enable incorporation of virus-specific spacers into the CRISPR locus or to trigger cell
suicide when the immune function of CRISPR-Cas systems fails. Similarly, toxin-like activity is predicted for
components of numerous other defense loci.
Implications of the hypothesis: The hypothesis implies that antivirus response in prokaryotes involves key
decision-making steps at which the cell chooses the path to follow by sensing the course of virus infection.
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Viruses are the most abundant biological entities on
earth. In well-characterized habitats such as seawater
and soil the number of viral particles exceeds the num-
ber of cells by one to two orders of magnitude [1-3].
Thus, all bacteria and archaea exist in a perennial arms
race with the excessively abundant viruses [4,5]. Conse-
quently, prokaryotes have evolved extremely diverse and
elaborate antiviral defense systems that occupy a sub-
stantial part of the genome in all free-living prokaryotes
[6]. Antivirus defense systems can be classified into two
broad categories that differ in their general principles of
action. Immune systems function on the self-nonself
discrimination principle, i.e. specifically recognize and
destroy foreign genomes while protecting the host gen-
ome (Figure 1). In addition to targeting viral genomes,
these systems are also involved in other inter-genomic
conflicts with selfish elements such as plasmids. In con-
trast, suicide systems execute cell death or dormancy
programs that prevent a virus from completing its
reproduction in the given infected cell and subsequently
infecting other cells [7]. The self-nonself discrimination
principle is employed, in particular, by the restriction-
modification (RM) systems, which are probably the best
characterized defense systems in prokaryotes, to a large
extent, because restriction endonucleases are essential
experimental tools of molecular biology [8-10]. Recently,
an analogous system of DNA phosphorothioation (known
as the DND system) has been characterized [11-13]. The
RM and DND systems may be considered mechanisms
of innate immunity: they do not adapt to a specific infec-
tious agent but simply ensure protection of the self
DNA and attack non-self invaders indiscriminately. The
CRISPR (clustered regularly interspaced short palin-
dromic repeats)-Cas (CRISPR-associated genes) systems
that are encoded in the genomes of the great majority of
archaea and many bacteria represent another type of
defense machinery that is also based on self-nonselfFigure 1 The defense systems in prokaryotes: innate immunity, adapdiscrimination but fits the definition of adaptive (as
opposed to innate) immunity [14-18]. Unlike the RM and
DND systems that generically distinguish between modi-
fied and unmodified recognition sites in DNA, the
CRISPR-Cas systems function via adaptation to a specific
infectious agent. The CRISPR-Cas first incorporates a
unique fragment of the invading DNA into a specific
locus in the host genome and then employs the tran-
scripts of these unique spacers to target the cognate
sequences in viral or plasmid genomes, achieving ex-
tremely high levels of immunity as the result.
The toxin-antitoxin (TA) and abortive infection (ABI)
systems that are nearly ubiquitous and highly abundant
in bacteria and archaea typically cause cell suicide or
dormancy in response to virus infection or other forms
of stress [7,19-26]. Under normal conditions, the toxin
component of a TA system is kept inactive through the
association with the antitoxin but under stress the anti-
toxin is inactivated and the toxin is unleashed. These
systems employ several molecular mechanisms, the most
common one being the cleavage of translated mRNA
directly on the ribosomes by toxins that possess nuclease
(interferase) activity. The evolution of a suicidal response
via toxin action might be explained by invoking altruism/
kin/group selection: when immune systems fail to pre-
vent virus reproduction, the TA and ABI systems kill the
infected cell or render it dormant, hence increasing the
survival chance for the surrounding cells [7,19-26]. Such
altruistic behavior is particularly likely to be selected for
in situations where the neighboring cells are kin emer-
ging from clonal expansion and/or when cells have other
factors favoring cooperation, such as aggregation in a
biofilm. Indeed, a recent study combining experimental
analysis of virus-host interaction with mathematical mod-
eling and simulation has shown that bacterial “Suicidal
Defense Against Infection” is efficient in a spatially struc-
tured habitat but under well-mixed conditions [27]. The
dormancy route not only attains the same end buttive immunity and programmed suicide/dormancy.
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cell itself.
Comparative genomic analysis of the genes encoding
defense systems in archaea and bacteria revealed statisti-
cally significant genomic clustering of RM, ABI and TA
systems (but not CRISPR-Cas) within defense islands
[6]. Furthermore, several specific, tight associations were
observed. In particular, the abortive infection system
AbiU1/AIPR is frequently associated with RM [28]. Two
additional architectural associations of the same type
have been reported for two previously uncharacterized
domains Ymh (Pfam09509) and DUF4145 (Pfam13643),
with the latter domain being fused to restriction subu-
nits of RM type I systems.
Whether the connection between immune and suicidal
defense systems involves any form(s) of specific functional
cooperation or occurs fortuitously due to non-adaptive
clustering of horizontally transferred genes remains un-
clear [6]. However, in one well-studied model such
cooperation has been discovered. This case involves the
Escherichia coli anticodon nuclease (ACNase) PrrC which
contributes to the T4 phage exclusion mechanism as a
component of the RM type Ic system PrrI [29]. The prrC
gene co-localizes with the cluster of genes for the 3 sub-
units of a RM system (hsdMSR), and this genomic asso-
ciation is conserved in diverse bacteria, suggestive of
functional coupling. Normally, PrrC persists as an inactive,
latent endoribonuclease in association with the Hsd com-
plex but it can be allosterically activated either by unmodi-
fied DNA, or by increased levels of dTTP or by the small
anti-restriction peptide encoded by the T4-like enterobac-
teriophages. The activated PrrC ACNase cleaves the anti-
codon of tRNALys in a GTP-dependent manner, with GTP
hydrolysis catalyzed by the N-terminal ABC NTPase do-
main of PrrC. The cleavage of tRNALys inhibits transla-
tion and abrogates the growth of pnk (polynucleotide
kinase) or rnl1 (RNA ligase) mutants of T4. In wild type
T4 and related phages, Pnl and Rnl1 jointly function as
an antidote to PrrC by repairing the cleaved tRNA at the
20,30 cyclic phosphate and 50 OH [30,31]. The ACNase
RloC that is homologous to PrrC, although usually not
linked directly to RM systems, seems to function under
the same logic, i.e. as an antiviral contingency that acts
when DNA restriction is alleviated under genotoxic
stress [32,33]. Although PrrC and RloC are not known to
cause bacterial suicide or persistence, they clearly func-
tion on the exact same principle, namely inhibiting trans-
lation to prevent virus reproduction in situations when
an innate anti-phage immunity mechanism fails. Indeed,
an analogous but completely independent mechanism of
translation inhibition has been demonstrated to be crit-
ical in a parallel defense system that is deployed against
T4 by certain strains of Escherichia coli. Here, a defective
prophage produces a toxin known as Lit that contains azincin-like metallopeptidase domain and cleaves the
elongation factor Tu thereby instigating cell suicide or at
least abolishing translation in the bacterial cell infected
by T4. This system has been shown to prevent the spread
of T4 to the remaining cells in the colony [34,35].
We were interested in the possibility that echeloning
of suicidal/persistence-based defenses and directed attack
on viral nucleic acids via genomic coupling could be a
general phenomenon in prokaryotes. Here we present
evidence of association of TA/ABI systems with RM,
DND and CRISPR-Cas systems and outline the hypoth-
esis that all classes of prokaryotic immunity systems
function in direct cooperation with suicide or persistence
(dormancy) mechanisms.
Presentation of the hypothesis
We first consider the CRISPR-Cas systems of adaptive
immunity. The recent experimental breakthroughs seem
to have revealed all the genes that are responsible for
DNA/RNA targeting [15,36-43] and spacer integration
[44] by CRISPR-Cas. However, several genes that are
stably associated with CRISPR-Cas loci still do not fit
into this scheme [45] (Figure 2A).
The only two genes that are universal among the
CRISPR-cas systems are cas1 and cas2 both of which are
implicated in the first stage of CRISPR-Cas function,
adaptation, or spacer integration [44]. However, despite
the genetic evidence of the involvement of both genes, all
the enzymatic activities required for adaptation appear to
be provided by Cas1 alone [44]. The Cas2 protein has
been shown to possess a sequence-specific endoribonu-
clease activity [47] and is a homolog of the VapDHi toxin
of the VapDHi/VapX TA system from Haemophilus influ-
enzae [47-50]. Therefore it appears highly likely that like
VapDHi, Cas2 is an mRNA interferase that specifically
cleaves ribosome-associated mRNAs, an activity that is
mechanistically irrelevant for the adaptation stage of the
CRISPR-Cas function. Furthermore, certain Cas2 homo-
logs occur independently of an antitoxin in predicted
operons or in genomic contexts corresponding to mobile
selfish elements that are able to mediate their replication
in conjunction with transfer. In these cases, the Cas2-
homologs are typically in the neighborhood of a gene en-
coding a resolvase (e.g. gi: 57504998, from Campylobacter
coli RM2228) or a Mob-type relaxase (gi: 313144877 from
Helicobacter cinaedi). Conceivably, the endoRNase activity
of these Cas2 homologs might foster addiction to the
respective mobile elements via toxin-like action upon dis-
ruption of the selfish element. Furthermore, the combin-
ation of the Cas2-like protein with a DNA resolving/
cleaving enzyme is reminiscent of the CRISPR-Cas sys-
tems where Cas1, the partner of Cas2, plays the key
role in the integration of the acquired spacer DNA.
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Figure 2 (See legend on next page.)
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Figure 2 Organization of the genomic loci that encode prokaryotic immune systems including toxin genes. The core genes of
CRISPR-Cas, RM, and DND systems in predicted operons are shown by pink arrows; genes with (predicted) toxin activity are shown by different
colors, and the (predicted) toxin domains are denoted with red outline. The Csa3 protein in the Type IA system lacks the HEPN domain.
Abbreviations: HEPN - higher eukarytoes and prokaryotes nucleotide-binding domain; Sir2, ParB and REase, DEDD are nucleases from distinct
superfamilies. A. CRISPR-Cas. Gene names follow the nomenclature and classification from [18]. B. Restriction-modification. Gene names follow the
nomenclature and classification from [46]. C. Phosphorothioation. Gene names follow the nomenclature from [12]. D. Prokaryotic argonaut, pAgo.
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ancient mobile element [47] similar to the aforemen-
tioned elements that combine Cas2-like genes with genes
encoding DNA resolving/cleaving enzymes. Therefore,
we hypothesize that Cas2 retains its ancestral toxin-like
EndoRNase function within the CRISPR-Cas systems but
the interferase activity is kept in check through reversible
inhibition by the Cas2-Cas1 interaction. This scheme is
proposed as a direct analogy to the control mechanism
of PrrC which is kept in its latent state via the interaction
with the associated RM system.
Under this hypothesis, when CRISPR-Cas fails to con-
tain virus growth due to viral counter-attack and/or the
level of genotoxic stress increases due to the accumulation
of nucleotide metabolites synthesized by viral enzymes,
Cas2 is activated (possibly through degradation of Cas1)
and abrogates translation, probably leading to cell suicide
or dormancy (Figure 3). The requirement of Cas2 for spa-





toxin activated by infection
Activated toxin
Immune system component with antitoxin
function
Figure 3 The immunity-dormancy/suicide coupling hypothesis: Route
between dormancy-suicide and immunity is specifically illustrated by the C
spacer during a dormancy-like phase induced by the action of the toxin (tyof Cas1 via Cas1-Cas2 complex formation that also re-
versibly inactivates Cas2. Perhaps even more important,
Cas2 might act at the initial stage of the CRISPR-Cas re-
sponse by rendering the infected cell dormant and hence
‘buying time’ to allow the CRISPR-Cas system to integrate
virus-specific spacers for effective future use in anti-
virus response. The strong sequence conservation of
Cas2 across the CRISPR-Cas systems, together with its
sequence-specific endoribonuclease activity, appear to
be better consistent with “self” RNAs being targeted ra-
ther than non-self RNAs which would likely select for
greater diversity of Cas2 [51]. Of interest in this regard is
the fusion of Cas2 with a 30-50 exonuclease RNaseH fold
domain (e.g. LSEI_0356 from Lactobacillus casei ATCC
334), which is present in several Type I-E CRISPR-Cas
loci. In these fusion proteins, Cas2 appears to be inacti-
vated as a result of substitution of the catalytic residues
so that the ribonuclease activity is most likely supplied by
the 30-50exonuclease-like domain [52].stem Toxin





1 – toxin action before immunity activation. The coupling
RISPR-Cas system that is hypothesized to adapt by inserting a cognate
pically, Cas2).
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encompass additional domains, besides Cas2, which
could potentially function similarly to toxins (Figure 2A).
Typically, these predicted toxins are either fused to or
encoded in the same operon with proteins of COG1517
(also known as Csm6 and Csx1) that are common in
CRISPR-Cas systems (Figure 2A). Most COG1517 pro-
teins contain a distinct Rossmann-fold domain [5,49] but
many in addition contain a third, usually C-terminal
domain. The domains fused to COG1517 proteins include
REase fold DNases (Pfam Clan: PD-(DE)xK) [49], as con-
firmed by a recently solved crystal structure (pdb code
1XMX), and HEPN domains ([53] and (KSM, VA, EVK,
LA, unpublished). The HEPN domain has been predicted
to comprise a component of a distinct TA jointly with
the minimal nucleotidyltransferase domain [25]; recently,
HEPN has been shown to function as a toxin [54]. Our
recent analysis suggests that the PrrC/RloC ACNase do-
main and the KEN domain of eukaryotic unfolded pro-
tein response/ antiviral RNAses (Ire1/RNAse L) also
are distinct versions of the HEPN fold and accordingly
that several HEPN domains are RNases with a toxin-type
activity (KSM, VA, EVK, LA, unpublished). Additional
notable architectures of this CRISPR-CAS associated
Rossmann-like domain include fusions to distinct RNase
domains with potential toxin activity such as the RelE
(e.g. sll7062 from Synechocystis sp. PCC 6803) and PIN
(e.g. APE_2119.1, Aeropyrum pernix K1) [55]. Both these
toxins have been shown to possess mRNA interferase
activity [24]. Most of the predicted toxin-like genes are
located within or in a close proximity of predicted
Type III CRISPR-Cas operons [18].
Moreover, the widespread Cas4 protein, a REase fold
nuclease that is part of most Type I CRISPR-Cas systems
but for which no specific function in the CRISPR-Cas re-
sponse so far has been established also might exhibit a
toxin-like activity. In this respect three observations seem
to be relevant: first, the aforementioned fusion of the
REase fold nuclease domain with the Rossmannoid do-
main; second, the only CRISPR-Cas Type I-A locus so far
detected in which the COG1517 protein (Csa3) does not
contain a potential toxin domain encompasses Cas4
(KSM, unpublished); third, the fusion of Cas4 with Cas1
[18]. The Cas4-Cas1 fusion may be considered in parallel
with the fusion of Cas1 with the reverse transcriptase
(RT) domain that was described previously [49] and now
appears to be widespread in a variety of bacteria (e.g.
alr1468 from Nostoc sp. PCC 7120, Franean1_1369 from
Frankia sp. EAN1pec, VVA1544 from Vibrio vulnificus
YJ016, etc.). The RT domain fused with Cas1 is related
to the RT-like proteins of the AbiA and AbiK families
that participate in the abortive infection response [56].
Recently, it has been shown that AbiK is not a typical
RT but apparently catalyzes non-templated synthesis ofrandom sequence DNA that remains covalently attached
to the protein and contributes to abortive infection via a
still uncharacterized mechanism [57]. We propose that
the Cas1-associated RT functions in a similar fashion.
Thus, within the CRISPR-Cas systems, multiple cases of
replacement of one type of toxin by another seem to
occur.
Similarly to CRISPR-Cas, defense systems that are best
classified as innate immunity are also associated with
suicide/dormancy genes. In addition to the PrrC-PrrI link
discussed above, many other Type I and Type III RM sys-
tems encompass domains with potential toxin-like roles
including different families of HEPN domains as well as
Sir2, ParB and REase fold nucleases that are homologous
to abortive infection system subunits and predicted toxins
of TA systems [6] (Figure 2B). Thus, in the RM system the
same phenomenon of repeated toxin displacement as in
the CRISPR-Cas systems seems to take place.
Although the specific functions of the proteins involved
in DNA phosphorothioation and those that are involved
in the restriction by this system are poorly understood,
the sets of genes involved in both processes are relatively
well-defined [11-13] (Figure 2C). One of the genes (dndB)
that is part of the phosphorothioation operon is a nega-
tive regulator of the process and might play a role in dis-
criminating between the modification of self and non-self
DNA [13,58]. The N-terminal domain of DndB belongs
to the AbiU1/AIPR family of abortive infection proteins
that are also linked to Type III RM systems [28]. The
AIPR proteins contain an N-terminal HEPN domain that
is a toxin and a predicted RNase (see above). Another
HEPN domain is present in the DndF protein that is
implicated in the restriction process [11-13].
Other, poorly characterized prokaryotic defense sys-
tems also might contain toxin domains (Figure 2D). In
particular, it has been predicted that prokaryotic Argonaut
protein (pAgo) is a key component of a distinct defense
system that can be encoded by a stand-alone gene or
within putative operons together with several nucleases
[59]. Notably, one of these nucleases is a close homolog of
Cas4 that might function as a toxin in conjunction with
CRISPR-Cas systems [59]. In addition, other REase fold
DNases as well as a predicted Sir2 superfamily enzyme are
often found in association with pAgo [59]. Thus, notably,
(predicted) Sir2 superfamily enzymes are distinct compo-
nents of the ABI system AbiH, and are linked both to
Type I RM systems and to the putative defense system
centered around pAgo (Figure 2A and 2D). These
enzymes might either function as mono-ADP-ribosylating
toxins targeting proteins or DNA [60] or as nucleases as
has been proposed for the Sir2 enzymes found in systems
containing HerA-FtsK-like proteins [61].
Most likely, there are additional, still uncharacterized
innate and/or adaptive immunity defense systems in
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cently studied example is the phage and chemical stress
resistance systems centered on the ter genes [62]. Several
operons of these systems combine genes encoding
nucleases and helicases similar to those found in RM sys-
tems with genes encoding COG1517 family proteins as
well as putative toxins related to those in typical TA sys-
tems. The latter proteins include Doc domains, which
modify proteins by addition of NMP moieties, and pre-
dicted RNases homologous to RelE, barnase or the PIN
domain. It seems likely that these systems also engender
higher level functional cooperation between the restric-
tion DNAses that directly target invading DNA and tox-
ins that promote dormancy or suicide. These operons
also share components with the Pgl system of reverse
restriction-modification that encompasses many genes
whose functions remain unclear although some of these
encode domains suggestive of toxin-like activities [6]
(VA, L.M. Iyer, LA, unpublished).
We are now in a position to formulate the immunity-
dormancy/suicide coupling hypothesis according to which
immune systems and cell dormancy/suicide systems
such as TA are functionally coupled and directly regulate
each other’s functions (Figure 3). Stand-alone suicide/
dormancy modules, such as typical TA systems, lack a
direct, demonstrable role in immunity and might even
decrease the fitness of the host, especially when theyImmunity sy





Immune system component with antitoxin
function
Figure 4 The immunity-dormancy/suicide coupling hypothesis: Route
dormancy-suicide and immunity is illustrated by the CRISPR-Cas system asexhibit their toxic activity in the context of plasmid
addiction or restriction attack upon disruption of RM
systems. However, the comparative genomics data sum-
marized here indicate that all major antivirus immunity
systems identified to date in prokaryotes are linked to
proteins that are homologous to toxin subunits of typical
suicide/dormancy modules and are predicted to possess
toxin-like activities. These toxin-like proteins might not
be mechanistically involved in the immune function but
rather could act similarly to their toxin counterparts from
stand-alone suicide/dormancy modules.
In most cases, the characterized and predicted toxin
proteins in immune systems are highly variable both in
terms of (potential) targets (i.e. DNA, tRNA, rRNA or
mRNA) and mechanism of action (i.e. protein modifica-
tion or nucleic acid degradation). However, if our predic-
tion of the toxin-like interferase function for Cas2 is valid,
the coupling between immunity and suicidal/dormancy
response is an intrinsic feature of all CRISPR-Cas systems.
Indeed, such coupling might be critical for the effective-
ness of the adaptive CRISPR-Cas systems. Given that anti-
virus defense by these adaptive immunity systems depends
on preliminary infection to integrate virus-specific spacer
DNA, a dormancy response through the action of Cas2 is
likely to help the host to ‘buy time’ to prime the immunity
response. Under the current hypothesis, this is the first
route of involvement of dormancy/suicide modules instem Toxin
Immunity fails, toxin activated
Cell and virus death
Immunity system Toxin
Immunity system Toxin
2 – toxin action after immunity failure. The coupling between
in Figure 3.
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precedes and enables the immune response (Figure 3).
The second route of immunity-suicide coupling follows
an even more straightforward biological rationale: when
an immunity system fails and/or the level of genotoxic
stress increases through the activity of metabolic enzymes
encoded by the infecting virus, the cell employs the asso-
ciated toxins for drastic measures that involve abrogation
of key cell processes, typically translation, leading to cell
death or dormancy (Figure 4).
Immunity systems do not encode typical antitoxins.
Therefore (and by analogy with the PrrC model), we
hypothesize that components of the immunity systems
themselves (e.g. Cas1) function as reversible inhibitors of
the toxic components, and that they are inactivated by
genotoxic stress or viral counter-defenses neutralizing
the immunity system and thus unleashing the toxin
(Figures 3 and 4).
Testing the hypothesis
Clearly, the immunity-suicide coupling hypothesis gener-
ates numerous predictions that can be tested experimen-
tally on diverse prokaryotic defense systems. Such tests
would involve biochemical experiments to detect the ac-
tivity of predicted toxin-like proteins, such as Cas2, as
well as computational searches for novel toxin-like pro-
teins among products of completely uncharacterized
genes within defense loci. Given that many of the toxins
are highly diverged, small proteins [25], the latter ap-
proach is expected to yield numerous new findings. In
addition, in trans interactions between immunity systems
and TA modules cannot be ruled out. Beyond direct
characterization of enzymatic activities, physical interac-
tions between (predicted) toxins and components of im-
mune systems (e.g. Cas1-Cas2) represent important
targets for experimental testing of the hypothesis.
Implications of the hypothesis
A general implication of the immunity-suicide coupling
hypothesis is that infected bacterial or archaeal cells rou-
tinely make decisions on the nature of their response to
virus infection: induction of a dormancy-like state to
allow priming of immunity; immediate immune response;
or dormancy/suicide in the face of immune system failure.
Apparently, these decisions are made through sensing the
course of the virus infection. Such decision-making could
be highly complex and might potentially involve diverse
signal transduction systems similarly to the sporulation-
competence decision in Bacillus subtilis that has been
mathematically modeled and experimentally character-
ized [63,64]. Mathematical modeling of the immunity-
dormancy networks has the potential to reveal unexpected
properties and functional regimes of prokaryotic defense
systems.Competing interest
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Reviewers’ reports
Reviewer 1: Dr. Arcady Mushegian, Stowers Institute for Medical Research,
Kansas City
The study by Makarova et al. notes that most of the operons encoding
bacterial immunity systems (i.e., restriction-modification, DNA
phosphorothioation, and CRISP-Cas) are associated with the known or
predicted suicide/dormancy systems (i.e., toxin-antitoxin and abortive
infection). The hypothesis is that bacteria are playing zone defense, which
apparently can take two different forms: first, if immunity system fails to
mount an efficient response to non-self DNA, then a suicide system is
activated to kill the cell and prevent the completion of virus infection;
second, if immunity system is slow to mount a response to non-self DNA,
then a dormancy system may shift cell metabolism in low gear, perhaps
slowing down virus reproduction and ‘buying time’ for the immunity system
to catch up. Somehow, these two versions of the echeloning are not
presented as two distinct responses, despite their opposite outcome, but are
discussed interminglingly; perhaps it would be better to state them as the
alternatives.
Authors’ response: We agree that the two routes of dormancy-immunity
coupling, one where dormancy is proposed to enable immunity and the other
one where the transition to dormancy or actual suicide follows immunity failure,
are best clearly distinguished. This is how we treat the subject in the revised
manuscript including the Abstract and the modified Figure 3 and new Figure 4.
The idea, nonetheless, is of a considerable interest. It comes with many
specific predictions of novel functions and domain architectures of the
involved proteins. In addition to all this, it is hypothesized that Cas system
itself has a built-in Kingston valve, consisting of the ubiquitous Cas2
component that acts as a suicidal toxin when released from its inhibitory
interaction with Cas1, which has an antitoxin function. The main open
question in my mind is whether the tight control of the zone defense of the
suicidal variety is possible. Failure or slowness of the cell to
mount the immunity response has to be sensed neither too early (otherwise,
futile destruction of the cell that was mounting said response just fine) nor
too late (otherwise, destruction only releases already-formed virus progeny).
This has to be recognized as an intrinsic difficulty; perhaps dormancy
response is more flexible in this regard.
Authors’ response: This comment is very much along the lines of the
Implications section in the revised manuscript. As we note in this section,
mathematical modeling of the coupled immunity-dormancy response is likely to
reveal different regimes and perhaps provide at least tentative answers to the
questions posed in this comment that could then become experimentally
tractable.
Minor comments:
“[defense island formation] occurs fortuitously due to non-adaptive
clustering of horizontally transferred genes” — perhaps horizontally
transferred genes may also cluster adaptively, but not because of their
molecular functions but because, for example of the advantage in avoiding
the established genome neighborhoods?
Authors’ response: indeed, this is conceivable as discussed previously [6].
“Cas2 .... is a homolog of the VapD toxin of the VapD/VapX TA system [41-
44]. Therefore it appears highly likely that analogously to VapD, Cas2 is an
mRNA interferase. . .” — two homologs have the same function; somehow,
‘analogously’ does not belong here.
Authors’ response: perhaps, this was indeed awkward, modified.
is it out of the realm of possibility that Cas-associated reverse transcriptases
could act on virus RNA, rare as the RNA bacteriophages are?
Authors’ response: the data discussed in the article seem to point in a
difference direction; yet, we agree, the involvement of the RT in the CRISPR-Cas
response to RNA viruses is not entirely inconceivable
Reviewer 2: Dr. Etienne Joly, Université Paul Sabatier, Toulouse
kin selection/altruism may play a very significant role in the way bacteria
combat against viruses, by committing suicide (or dormancy) rather than
letting the virus complete its infectious cycle. The main ground for this
This manuscript presents an interesting hypothesis whereby
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http://www.biology-direct.com/content/7/1/40hypothesis is that many, if not most, antiviral operons contain proteins that
appear more likely to play a role in causing the suicide (or dormancy) of the
host than against viruses. My main comment is that I wish to congratulate
the authors for the remarkable improvement of their manuscript compared
to the initial version. The manuscript is now much easier to read and
comprehend for someone like me who is not directly involved in this field: it
is now much easier to see what was already known, what the speculations
and hypotheses presented are, and to see how these could be confirmed or
infirmed by the predictions made.
Authors’ response: We greatly appreciate these comments.
Reviewer 3: Dr. Nick Grishin, University of Texas Southwestern Medical
Center, Dallas
In this short manuscript an interesting hypothesis is suggested that
immunity and suicide in bacteria may be linked by location of immunity
genes and suicide nuclease genes within the same operon. Moreover, due
to the lack of known antitoxins encoded in such operons, immunity proteins
may serve as reversible inhibitors of these nucleases that would cause cell
death when immune response fails. The hypothesis is supported by the
following evidence: abundance of nucleases without clear functional roles in
the operons of all major bacterial immunity systems; extensive functional
characterization of CRISPR-cas system failed to pinpoint the function of
essential Cas2 suggesting that Cas1 enzymatic activity is sufficient; Cas2 is
homologous to the VapD toxin (nuclease); deteriorated Cas2 proteins may
be fused with other, possibly active nuclease domains. All these small pieces
of incidental evidence and more are not likely to be fortuitous and indeed
the hypothesis suggested by the authors seems very attractive and worthy
of experimental exploration. However, it is also possible that some of these
nucleases do have other functions in immunity and such functions have not
been discovered yet. In any case, experimental study of an uncharacterized
protein is best to start from a testable functional hypothesis and this work
provides a highly plausible one. In addition, introduction and parts of the
results section read like an excellent review and a primer in bacterial
immunity for readers who are not particularly familiar with the subject. In
these regards, I think that the following recent papers might be relevant to
the discussion [4,27]
Authors’ response: We appreciate these comments and cited the suggested,
indeed highly relevant references in the revised manuscript.
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